Does BROLUCIZUMAB-DBLL Cause Uveitis? 305 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 305 reports of Uveitis have been filed in association with BROLUCIZUMAB-DBLL. This represents 10.9% of all adverse event reports for BROLUCIZUMAB-DBLL.
305
Reports of Uveitis with BROLUCIZUMAB-DBLL
10.9%
of all BROLUCIZUMAB-DBLL reports
1
Deaths
16
Hospitalizations
How Dangerous Is Uveitis From BROLUCIZUMAB-DBLL?
Of the 305 reports, 1 (0.3%) resulted in death, 16 (5.2%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Uveitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 305 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Visual impairment (446)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Retinal vasculitis (323)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
Anterior chamber cell (199)
What Other Drugs Cause Uveitis?
ADALIMUMAB (1,989)
INFLIXIMAB (1,046)
METHOTREXATE (930)
ETANERCEPT (742)
INFLIXIMAB-DYYB (720)
SECUKINUMAB (643)
PREDNISONE (361)
GOLIMUMAB (354)
NIVOLUMAB (347)
AFLIBERCEPT (337)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Uveitis Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM